ジスロマックカプセル小児用１００ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00207 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 68 |
| 日本商品名（例） | アジスロマイシン小児用細粒１０％「タカタ」 １００ｍｇ, アジスロマイシン小児用錠１００ｍｇ「タカタ」, アジスロマイシン細粒小児用１０％「トーワ」 １００ｍｇ |
承認適応症（KEGG）
歯周組織炎、マイコバクテリウム・アビウムコンプレックス(MAC)症、結膜炎、眼瞼炎
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | Mycoplasma pneumoniae pneumonia | 99% | DL |
| 2 | conjunctivitis | 99% | DL |
| 3 | hyperamylasemia | 99% | DL |
| 4 | polyclonal hyperviscosity syndrome | 99% | DL |
| 5 | congenital analbuminemia | 99% | DL |
| 6 | punctate epithelial keratoconjunctivitis | 99% | DL |
| 7 | blood group incompatibility | 99% | DL |
| 8 | acute contagious conjunctivitis | 99% | DL |
| 9 | premalignant hematological system disease | 99% | DL |
| 10 | monoclonal gammopathy | 99% | DL |
| 11 | hematological disease associated with an acquired peripheral neuropathy | 99% | DL |
| 12 | septicemic plague | 99% | DL |
| 13 | congenital hematological disorder | 99% | DL |
| 14 | exposure keratitis | 99% | DL |
| 15 | necrotizing ulcerative gingivitis | 98% | DL |
| 16 | lymphogranuloma venereum | 98% | DL |
| 17 | postinfectious vasculitis | 98% | DL |
| 18 | post-bacterial disorder | 98% | DL |
| 19 | post-infectious syndrome | 98% | DL |
| 20 | otitis externa | 98% | DL |
| 21 | infective urethral stricture | 98% | DL |
| 22 | Chagas cardiomyopathy | 98% | DL |
| 23 | infection-related hemolytic uremic syndrome | 98% | DL |
| 24 | chronic gingivitis | 98% | DL |
| 25 | bubonic plague | 98% | DL |
| 26 | bacterial pneumonia | 97% | DL |
| 27 | Klebsiella pneumonia | 97% | DL |
| 28 | pneumonia of swine, mycoplasmal | 97% | DL |
| 29 | amebic dysentery | 97% | DL |
| 30 | parasitic eyelid infestation | 97% | DL |
| 31 | anthrax infection | 97% | DL |
| 32 | dysentery | 97% | DL |
| 33 | ulcerative blepharitis | 96% | DL |
| 34 | non-human animal disease | 96% | DL |
| 35 | trachoma | 96% | DL |
| 36 | blepharoconjunctivitis | 96% | DL |
| 37 | noninfectious dermatoses of eyelid | 96% | DL |
| 38 | hematopoietic and lymphoid system neoplasm | 96% | DL |
| 39 | chlamydia trachomatis infectious disease | 95% | DL |
| 40 | infectious otitis interna | 95% | DL |
| 41 | gastrin secretion abnormality | 95% | DL |
| 42 | pneumonia caused by gram negative bacteria | 95% | DL |
| 43 | acute gonococcal cervicitis | 94% | DL |
| 44 | chronic tubotympanic suppurative otitis media | 94% | DL |
| 45 | paratyphoid fever | 94% | DL |
| 46 | L-ferritin deficiency | 94% | DL |
| 47 | epidemic keratoconjunctivitis | 93% | DL |
| 48 | salmonellosis | 93% | DL |
| 49 | neurotrophic keratopathy | 92% | DL |
| 50 | chronic rhinosinusitis | 92% | DL |
（上位50件を表示。全68件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。